Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose de Leon

Showing results (51-60 of 381) with videos related to

Pageof 39
Sort By:
Psychiatric Services (Washington, D.C.)|May 7, 2004
Atypical antipsychotic dosing: the effect of smoking and caffeineJose de Leon
Science (New York, N.Y.)|August 9, 2008
The potential of genotypingJose de Leon
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 19, 2008
Pharmacogenomics: the promise of personalized medicine for CNS disordersJose de Leon
The Journal of Nervous and Mental Disease|May 26, 2021
Reflections on US Psychiatry: How the Baton Was Passed From European Psychiatry and the Contributions of US PsychiatryJose de Leon
Journal of Clinical Psychopharmacology|February 15, 2014
False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology. Part I: focus on epilepsyJose de Leon
Journal of Clinical Psychopharmacology|March 18, 2008
Beyond the "hype" on the association between metabolic syndrome and atypical antipsychotics: the confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid substance useJose de Leon
Therapeutic Drug Monitoring|October 22, 2019
Future Studies on the Interaction Between Clozapine and Valproic Acid Should Aspire to Include Longitudinal Designs and Free Valproate Concentrations, and Should Consider that Inducer and/or Inhibitory Effects May Vary With Time, the Individual, and the Auto-Induction of Valproic AcidJose de Leon
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2014
Clinically relevant interactions between newer antidepressants and second-generation antipsychoticsEdoardo Spina, Jose de Leon
Current Psychiatry Reports|March 13, 2018
Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar DisorderJose de Leon, Edoardo Spina
Asian Journal of Psychiatry|July 13, 2025
The clozapine package inserts need to reflect lower doses for AsiansJose de Leon, Rajiv Tandon
Pageof 39

Showing results (51-60 of 381) with videos related to

Sort By:
Pageof 39
Psychiatric Services (Washington, D.C.)|May 7, 2004
Atypical antipsychotic dosing: the effect of smoking and caffeineJose de Leon
Science (New York, N.Y.)|August 9, 2008
The potential of genotypingJose de Leon
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 19, 2008
Pharmacogenomics: the promise of personalized medicine for CNS disordersJose de Leon
The Journal of Nervous and Mental Disease|May 26, 2021
Reflections on US Psychiatry: How the Baton Was Passed From European Psychiatry and the Contributions of US PsychiatryJose de Leon
Journal of Clinical Psychopharmacology|February 15, 2014
False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology. Part I: focus on epilepsyJose de Leon
Journal of Clinical Psychopharmacology|March 18, 2008
Beyond the "hype" on the association between metabolic syndrome and atypical antipsychotics: the confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid substance useJose de Leon
Therapeutic Drug Monitoring|October 22, 2019
Future Studies on the Interaction Between Clozapine and Valproic Acid Should Aspire to Include Longitudinal Designs and Free Valproate Concentrations, and Should Consider that Inducer and/or Inhibitory Effects May Vary With Time, the Individual, and the Auto-Induction of Valproic AcidJose de Leon
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2014
Clinically relevant interactions between newer antidepressants and second-generation antipsychoticsEdoardo Spina, Jose de Leon
Current Psychiatry Reports|March 13, 2018
Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar DisorderJose de Leon, Edoardo Spina
Asian Journal of Psychiatry|July 13, 2025
The clozapine package inserts need to reflect lower doses for AsiansJose de Leon, Rajiv Tandon
Pageof 39